Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-017270
Filing Date
2023-07-07
Accepted
2023-07-07 16:30:13
Documents
1
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5052
  Complete submission text file 0000899243-23-017270.txt   7414
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Reporting) CIK: 0000059478 (see all company filings)

State of Incorp.: IN | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39746 | Film No.: 231077101
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LILLY CORPORATE CENTER 893 DELAWARE STREET INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CENTER 893 DELAWARE STREET INDIANAPOLIS IN 46285 317-276-2000
Shenandoah Acquisition Corp (Reporting) CIK: 0001983165 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39746 | Film No.: 231077100